Spire Healthcare Group PLC (LON:SPI)‘s stock had its “equal weight” rating reaffirmed by equities research analysts at Morgan Stanley in a research report issued to clients and investors on Monday. They currently have a GBX 350 ($4.32) price target on the stock. Morgan Stanley’s price objective points to a potential upside of 4.95% from the company’s current price.

Other analysts have also recently issued reports about the stock. Numis Securities Ltd reissued an “add” rating and set a GBX 360 ($4.45) target price on shares of Spire Healthcare Group PLC in a report on Thursday, January 12th. Liberum Capital reissued a “buy” rating and set a GBX 400 ($4.94) target price on shares of Spire Healthcare Group PLC in a report on Thursday, March 2nd. Berenberg Bank reissued a “buy” rating and set a GBX 360 ($4.45) target price on shares of Spire Healthcare Group PLC in a report on Thursday, February 9th. Jefferies Group LLC dropped their target price on shares of Spire Healthcare Group PLC from GBX 335 ($4.14) to GBX 305 ($3.77) and set a “hold” rating on the stock in a report on Thursday, December 15th. Finally, JPMorgan Chase & Co. dropped their target price on shares of Spire Healthcare Group PLC from GBX 433 ($5.35) to GBX 376 ($4.64) and set a “neutral” rating on the stock in a report on Friday, March 10th. One analyst has rated the stock with a sell rating, five have given a hold rating and four have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and an average target price of GBX 356.80 ($4.41).

Analyst Recommendations for Spire Healthcare Group PLC (LON:SPI)

Shares of Spire Healthcare Group PLC (LON:SPI) traded up 0.72% during mid-day trading on Monday, hitting GBX 333.50. 659,527 shares of the company traded hands. The firm’s market cap is GBX 1.34 billion. Spire Healthcare Group PLC has a 52-week low of GBX 295.00 and a 52-week high of GBX 411.00. The firm has a 50-day moving average price of GBX 327.01 and a 200 day moving average price of GBX 350.89.

This article was originally published by and is the sole property of American Banking News. If you happen to be reading this article on another website, it was stolen and illegally republished in violation of U.S. and International copyright law. The original version of this story can be read at https://www.americanbankingnews.com/2017/03/20/spire-healthcare-group-plcs-spi-equal-weight-rating-reiterated-at-morgan-stanley.html

The company also recently disclosed a dividend, which will be paid on Tuesday, June 27th. Investors of record on Thursday, June 1st will be issued a GBX 2.50 ($0.03) dividend. This represents a dividend yield of 0.75%. The ex-dividend date of this dividend is Thursday, June 1st. This is a boost from Spire Healthcare Group PLC’s previous dividend of $1.30.

Your IP Address:

About Spire Healthcare Group PLC

Spire Healthcare Group plc is a United Kingdom-based independent hospital group. The Company provides in-patient, daycase and out-patient care from approximately 40 hospitals, 10 clinics and over two specialist care centers across the United Kingdom. The Company also owns and operates a sports medicine, physiotherapy and rehabilitation brand, Perform, and a screening service, Lifescan, as well as national pathology services.

Receive News & Ratings for Spire Healthcare Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group PLC and related companies with MarketBeat.com's FREE daily email newsletter.